mail
versión imprimible
 
 

BCMA Targeted Therapies

Evvnt Promotion / evvnt
-
12.07.2022 - 14.07.2022  The Bostonian, 26 North Street, 02109 Boston, Massachusetts, USA
Time: 9:00 AM - 4:30 PM
 
Temas de la conferencia
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
Organizador profesional (PCO)
Hanson Wade
 

Información e inscripción:

https://go.evvnt.com/1093163-2?pid=4832
Mr. Hanson Wade
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioCenter of ExcellenceCharité International AcademynewTreeÄrzte der WeltÄrztekammer für WienÖsterreichisches Rotes KreuzSwiss Tropical and Public Health Institute